Sabina, M.; Trube, J.; Shah, S.; Lurie, A.; Grimm, M.; Bizanti, A.
Finerenone: A Third-Generation MRA and Its Impact on Cardiovascular Health—Insights from Randomized Controlled Trials. J. Clin. Med. 2024, 13, 6398.
https://doi.org/10.3390/jcm13216398
AMA Style
Sabina M, Trube J, Shah S, Lurie A, Grimm M, Bizanti A.
Finerenone: A Third-Generation MRA and Its Impact on Cardiovascular Health—Insights from Randomized Controlled Trials. Journal of Clinical Medicine. 2024; 13(21):6398.
https://doi.org/10.3390/jcm13216398
Chicago/Turabian Style
Sabina, Michael, Jennifer Trube, Shrinand Shah, Andrew Lurie, Mason Grimm, and Anas Bizanti.
2024. "Finerenone: A Third-Generation MRA and Its Impact on Cardiovascular Health—Insights from Randomized Controlled Trials" Journal of Clinical Medicine 13, no. 21: 6398.
https://doi.org/10.3390/jcm13216398
APA Style
Sabina, M., Trube, J., Shah, S., Lurie, A., Grimm, M., & Bizanti, A.
(2024). Finerenone: A Third-Generation MRA and Its Impact on Cardiovascular Health—Insights from Randomized Controlled Trials. Journal of Clinical Medicine, 13(21), 6398.
https://doi.org/10.3390/jcm13216398